top of page

GENERIC DRUG MANUFACTURERS

Generic Manufacturers subscribe to IPD Analytics to help identify

ANDA opportunities, accessing in-depth, continuously-updated,
patent, regulatory, and competitive analysis. 

Asset 3-20.png

PATENT & REGULATORY

ANALYSIS

Gain a deeper understanding of drug protections and how they change over time with loss-of-exclusivity predictions on thousands of drugs in every major therapeutic category.

Asset 2-20.png

LEGAL

ANALYSIS

Let our litigation projections and
day-by-day coverage keep you up to date on impactful courtroom events, reducing legal costs with real-time updates and analyses on settlements, hearings, oppositions, and
appeals happening around the world. 

Asset 5-20.png

COMPETITIVE

INTELLIGENCE

View the entire competitive landscape from clinical-trial monitoring to loss of exclusivity and beyond, accessing summary data and analysis from hundreds of sources at the drug, company, disease, and technology level.

Asset 4-20.png

PAYER & PROVIDER

INSIGHTS

Understand how payor coverage decisions shape the value of your ANDA, evaluating risks and opportunities within the changing landscape surrounding complex generics, biosimilars, 505(b)(2) NDAs, and rare and orphan diseases.

bottom of page